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Abstract
Background: Prompt and appropriate treatment of streptococcal pharyngitis decreases the risk of acute rheumatic
fever and rheumatic heart disease (RHD). Understanding public perceptions and behaviors related to sore throat is
fundamental to inform health programs aimed at eliminating new cases of RHD in endemic regions. We sought to
describe the epidemiology of pediatric pharyngitis and its treatment, as reported by children and their parents or
guardians in Lusaka, Zambia.
Methods: This was a cross-sectional investigation using interviews and written surveys, nested in a school-based
RHD prevalence study. Students and their parents were asked to report number of sore throats in the previous
12 months, treatment received, and type and place of treatment. A focused history and physical examination to
detect pharyngitis was conducted and children were referred for follow-up as indicated.
Results: A total of 3462 students from 47 schools participated in the study, along with their parents or guardians.
Six hundred and fifty eight (19%) parents/guardians reported their child had at least one sore throat in the previous
year, and 835 (24%) of students reported at least one sore throat in the same time period. Girls were reported to
have pharyngitis 50% more often than boys, and also made up two-thirds of the total students treated.
Approximately two-thirds of children who had at least one episode of pharyngitis during the previous year were
also reported to have received some form of treatment. The majority of treatments were received in government
clinics (36.6%) and at home (26.3%). Half of treatments included an antibiotic. Nineteen students (0.5%) had
clinically-apparent pharyngitis at screening.
Conclusion: Pharyngitis is common among school-aged children and adolescents in Zambia, with females
reporting significantly more sore throat episodes than males. Parents/guardians have variable knowledge about the
frequency of sore throat in their children, and management of pharyngitis may be suboptimal for many children
since more than a quarter were reported to have received treatment without skilled assessment. These results
provide insight into current perceptions and practices related to sore throat in Zambia and will be used to design
public awareness activities aimed at reducing RHD.
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Background
Rheumatic heart disease (RHD) is a potential complica-
tion of untreated group A β-haemolytic streptococcal
(GAS) pharyngitis that is endemic in many low- and
middle-income countries and in some indigenous popu-
lations of high-income countries [1, 2]. RHD is a disease
of poverty and, as a reflection of its enduring neglect, ro-
bust assessments of its prevalence were reported for the
first time only several years ago. The Global Burden of
Disease Study (2015) estimated that more than 33 mil-
lion people are living with RHD [3] and 320,000 people
die of the disease each year [4]. In sub-Saharan Africa,
population-based screening studies using portable echo-
cardiography have consistently revealed rates of 1–3% in
schoolchildren [5–8].
Rheumatic heart disease is the consequence of an ab-
errant immune response following GAS pharyngitis,
whereby antibodies elicited to the bacterial pathogen
cross react with proteins in the heart [1]. If not treated
appropriately, GAS pharyngitis leads in a small percent-
age of patients to acute rheumatic fever (ARF). Rheum-
atic heart disease develops in nearly half of patients with
ARF and is typically characterized by progressive damage
to heart valves spurred by repeat exposures to GAS. Pa-
tients with RHD are at risk of debilitating heart failure,
stroke, endocarditis, and premature death [1].
New appreciation of the substantial burden of RHD
has led to expansion of health policy, programming, and
research aimed at combating the disease in endemic re-
gions [9–11]. A major focus is disease prevention. In this
regard, prompt and correct treatment of streptococcal
pharyngitis with antibiotics, known as primary preven-
tion, has emerged as a critical priority since it is the sin-
gular clinical activity known to decrease attack rates of
ARF and RHD [12, 13]. Primary prevention was recog-
nized to be a key component of successful national pub-
lic health initiatives in several countries [14, 15], and it
is highlighted as an essential practice by leading health
authorities including the World Health Organization,
the World Heart Federation, and the Pan African Society
for Cardiology [16, 17]. As a result, concerted efforts are
underway in various parts of the world, including in
sub-Saharan Africa, to scale-up health workers’ capability
to satisfactorily manage patients that present with sore
throat [9, 10].
GAS pharyngitis should be treated with antibiotics
within 9 days from onset to eliminate the risk of RHD
[18], and it is therefore incumbent on patients to
promptly seek skilled care when symptoms manifest. Yet
while the public’s role in anti-RHD efforts is paramount,
few if any large-scale RHD initiatives address the
demand-side barriers related to health seeking behaviors
and patterns of health care utilization that are common
in settings where the disease is prevalent. “Demand-side
barriers” are defined here as determinants of health care
utilization that operate at the individual, household, or
community level; they include educational, cultural, and
social factors [19]. As part of a multi-faceted public-
private partnership in Zambia to control and eventually
eliminate RHD, an awareness campaign was launched in
2014 with the primary aim of educating the public about
the link between pharyngitis and RHD. In order to in-
form relevant and effective campaign messaging, we
sought to understand baseline perceptions and behaviors
related to sore throat. A large-scale school-based screen-
ing program designed to measure RHD prevalence pro-
vided the opportunity to nest an investigation of the
epidemiology of pediatric pharyngitis and its treatment
as reported by children and their parents or guardians.
Methods
Study population
The study population consisted of healthy children and
young adults in Zambia’s capital, Lusaka, between
September 2014 and November 2015. Based upon
methods used previously [8], the population was drawn
from a random sample of grade 1–12 classrooms in pub-
lic primary and secondary schools. A study team mem-
ber approached the administrative head of each selected
school, discussed the proposed study, and invited partici-
pation. Study staff then also briefed teachers whose
classrooms were to be involved. The parents or guard-
ians of study participants provided written informed
consent. In addition, written informed assent was re-
quired from participants 8 years of age or older. Inclu-
sion criteria were all students who provided assent,
whose parents consented, and who were present at
school on the day of the study. Exclusion criteria were
conditions that precluded the performance of transtho-
racic echocardiography that was required for the disease
prevalence aspect of the study (e.g., skin infection of the
chest). This investigation was conducted in partnership
with the Zambian Ministries of Health and Education.
Ethics approval was granted from the University of
Zambia.
Data collection and management
This was an observational, cross-sectional investigation
using interviews and written surveys that was nested in
an RHD prevalence study. As part of the prevalence
study component (analyses in progress) a clinical nurse
practitioner examined students to detect signs of ARF or
RHD, and a trained technician performed a screening
echocardiogram to identify individuals with possible
clinical or subclinical RHD. For the current investiga-
tion, students and their parents or guardians were inter-
viewed or surveyed, respectively, and asked to report the
number of episodes of sore throat that students had in
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the previous 12 months and whether or not treatment
was received. If treatment was received, then efforts
were made to understand the type of therapy (e.g.,
whether or not an antibiotic was administered) and the
site of treatment. The Zambia national standard treat-
ment guidelines recommend penicillin in either oral or
intramuscular formulations to treat sore throat, and this
is the most widely observed practice. This study did not
attempt to describe what antibiotics specifically were ad-
ministered for treatment of pharyngitis.
A clinical nurse practitioner conducted a focused his-
tory and physical examination of each student to detect
for signs of pharyngitis at the time of the study. All stu-
dents identified by the nurse practitioner to possibly
have an abnormal clinical condition (including pharyn-
gitis, ARF, or RHD) were referred for follow up at a local
health clinic or at Lusaka University Teaching Hospital.
Data elements obtained by survey of parents or guard-
ians were recorded initially on paper-based case report
forms (by the parents or guardians themselves) and then
transcribed by two study nurses into a secure, digital
database (CommCare platform [20] an open-source,
cloud-based software platform for health programs that
supports the development of customized data-capture
tools [21]). Data elements acquired by survey of students
were obtained verbally and entered at the time of cap-
ture into the digital database using mobile electronic de-
vices (Samsung Galaxy Tab. 2 computer tablets). Data
relating to approximately 5% of subjects were verified
between paper and electronic forms to validate accuracy
of transcription. A data-extraction job was created to
export data from CommCare into Microsoft Excel
(Version 14.6.8) for analysis.
Statistical analysis
The study was powered for the RHD prevalence aspect
of the investigation. The sample size calculation took
into account the primary and secondary school popula-
tion in Lusaka (approximately 500,000), the point esti-
mate of 1% RHD prevalence in Lusaka (based on
previously conducted RHD prevalence studies from
other countries in sub-Saharan Africa), a 1.2 design ef-
fect for clustering in school classrooms, and a presumed
rejection rate of 9%. A sample size of at least 1024 par-
ticipants was determined to provide an estimate of RHD
prevalence within 0.7 percentage points of precision
with 95% confidence. Ultimately, the number of stu-
dents enrolled was greater than the minimum sample
size because echocardiography-related methodological
issues emerged after the study started and necessi-
tated expansion of the number of subjects. That de-
velopment had no effect on the current study other
than enlarging the population studied, still under a
randomization scheme.
Data analysis used the following methods: agreement
between numbers of sore throats reported by parents
and students was calculated using Cohen’s kappa, a
commonly used statistic to determine inter-rater agree-
ment for categorical variables. Linear regression was
used to identify variables that could be predictors of the
number of reported sore throats by children and par-
ents, and stepwise regression was used to determine
which variables to include in the model; statistically sig-
nificant variables at the 15% level were added to the
model one by one, and at each step previously added
variables that were no longer found to be significant at
the 15% level were removed once the new variable was
added.
Results
Demographic characteristics
A total of 3462 children and adolescents participated,
along with their parents or guardians. The families were
enrolled at 47 different Lusaka area schools; approxi-
mately 60–90 students participated from each included
school. The students ranged in age from 5 to 29 years,
with a median of 14.0 years old (Table 1). The majority
(98%) of students were ≤19 years of age. There were fif-
teen students ≥20 years of age (older students occasion-
ally attend secondary school in Lusaka if their previous
education had been disrupted by factors such as illness,
pregnancy, childbirth, and need to work).
Number of pharyngitis episodes as reported by student
and parent or guardian
Twenty-four percent of students reported experiencing
at least one sore throat in the previous year, with 4.6%
reporting at least three episodes. According to student
reports, the average number of sore throats in the previ-
ous year was 0.32 episodes per student. Nineteen per-
cent of parents and guardians reported their child had at
least one sore throat in the previous year, with 4.4%
reporting three or more episodes.
Parents or guardians did not know or did not report
sore throats about seven times more often than the
Table 1 Demographic characteristics of study participants
(students)
Age (years) Mean (SD) 14.09 (3.11)
Median 14.0
Gender - (n%) Male 1525 (44.04%)
Female 1937 (55.93%)
Weight (kg) Mean (SD) 45.8 (13.07)
Median 47.4
Height (cm) Mean (SD) 152.3 (14.37)
Median 155.1
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students (Table 2). Parents or guardians recalled a lower
number than the student in 494 cases (14%) and a
higher number in 324 cases (9%). In addition, when indi-
vidual parent/guardian-student pairs were analyzed, only
57% showed perfect agreement between reports (1967
out of 3462 pairs). Cohen’s kappa measure of agreement
was estimated to be 0.23 (95% C.I. 0.21–0.25), reflecting
a fair agreement between parent or guardian and child
for the reported number of sore throats in the past year
(Table 3). Younger children were significantly less likely
to agree with their parents/guardians on the recall of the
number of sore throat episodes; perfect agreement was
seen for 53% of pairs when children were ≤12 years old
and for 65% of pairs involving students >12 years of age
(p < 0.0001).
Predictors of reported pharyngitis episodes
A regression analysis with stepwise variable selection was
performed to identify predictors of the number of re-
ported sore throats among the following variables: age,
gender, weight, and height. The only variable that strongly
correlated with reports by both students and parents or
guardians was gender. Female students reported on aver-
age 0.13 more yearly episodes than male students (0.38 vs.
0.25, p < 0.0001). Similarly, parents or guardians reported
0.08 more yearly episodes for their daughters versus for
their sons (0.35 vs. 0.27, p = 0.0036).
Reported treatment methods and locations
Treatment practices for pharyngitis were collected based
on reports by the parent or guardian. Of the 658 parents
or guardians who reported at least one episode of sore
throat in the past year for their child, 609 also indicated
treatment practices. Of those, 180 students (30% of cases
where reports were available) received no treatment for
their pharyngitis episode(s), while 429 students (70% of
cases where reports were available) received treatment.
Treatment on three or more separate occasions was re-
ported for 93 students (15% of cases where reports were
available). The majority of reported treatments were re-
ceived in government clinics, and the second most com-
mon site of treatment was at home, presumably with
holistic therapies (Table 4). According to reports by the
parent or guardian, 216 (50%) of the 429 students who
were treated for sore throat in the previous year received
an antibiotic. There was no significant difference in the
proportion of sick boys or girls who received treatment
(67% vs 72%, respectively; p = 0.1975). Consistent with
the finding that more pharyngitis episodes were recalled
for girls, however, was that about two-thirds of the total
individuals who had been treated were girls (284 girls;
66%).
Comparison of reported and measured number of
pharyngitis episodes
At time of screening, 77 students (2.2%) reported sore
throat, while 19 students (0.5%) had signs visible on
physical examination (e.g., pharyngeal erythema, swell-
ing, or exudate) that were severe enough for the student
to be referred for follow-up. Based on the average yearly
number of sore throats reported by students (0.32) and
average symptom duration of 1 week per episode, the
expected occurence would be 0.6% of students with sore
throat on a given day. This prediction closely matched
Table 2 Reported number of sore throats in year prior to survey
Reported by
student
Reported by
parent/guardian
Frequency (%) Frequency (%)
Don’t know/missing response 124 (3.58) 890 (25.71)
Zero 2503 (72.30) 1914 (55.29)
One or two 675 (19.50) 505 (14.59)
Three or more 160 (4.62) 153 (4.42)
Total 3462 (100) 3462 (100)
Table 3 Agreement between number of pharyngitis episodes
reported by student and parent/guardian
Parent/Guardian
Student Don’t know/
missing response
0 1–2 3 Total
Don’t know/missing
response
58 43 16 7 124
0 634 1611 205 53 2503
1–2 160 224 248 43 675
3 38 36 36 50 160
Total 890 1914 505 153 3462
Boldfaced numbers indicate where there was perfect agreement between the
parent/guardian and student reports regarding number of sore throats in the
previous year
Table 4 Reported locations of treatment for pharyngitis
Treatment location N (%)
Government clinic 157 (36.6%)
Home 113 (26.3%)
Private clinic 66 (15.4%)
Hospital 57 (13.3%)
Chemist/pharmacist 47 (11.0%)
Traditional healer 1 (0.2%)
No location specified/Other 25 (6%)
Total number of treatments 466 (100%)
Note that the total number of treatments (and number of treatment locations)
is higher than the total number of students treated
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the measured number of clinically-apparent sore throats,
but underestimated the total reported sore throats by
about four-fold.
When considering all sore throats reported at screening,
there was no difference in mean age between children
reporting symptoms and the mean age of all participants
(both 14.1 years of age). More than double the number of
girls reported sore throats (52) compared to boys (25).
Discussion
To our knowledge this is the largest epidemiological sur-
vey investigating the frequency of pharyngitis in an RHD
endemic region in Africa as reported by school-aged
children or adolescents and their families, and the first
such study in Zambia. Understanding public perceptions
and behaviors related to sore throats has substantial im-
plications for the prevention of ARF and RHD. Table 5
lists a summary of key findings and the associated prac-
tical implications for future public awareness and educa-
tion activities in Zambia.
Pharyngitis was found to be common in Zambian stu-
dents. Approximately one in five students reported suf-
fering from a sore throat in the previous year and nearly
5% reported having three or more episodes. According
to student reports, this equated to an average of 0.32
sore throats per student per year. In Zambia the relative
frequency of GAS pharyngitis among all episodes of sore
throats (versus pharyngitis due to other etiologies such
as viruses) is unknown, but recent studies involving chil-
dren from other parts of sub-Saharan Africa reveal GAS
isolates in 25.5% (in Mali) and 21.6% (in South Africa) of
sore throat episodes [22, 23]. Applying the same ap-
proximate percentage to the survey data obtained in
Zambia gives a GAS pharyngitis attack rate of 0.08 cases
per student-year, which is consistent with other studies
globally albeit lower than has been previously found or
predicted in developing countries [24, 25]. The popula-
tion in Zambia is 17 million and about a third of the
population is aged 5–15 [26]. Using the data obtained in
this study, it would therefore be expected that an esti-
mated 440,000 school-aged children in Zambia are af-
fected by GAS pharyngitis annually. This compares
reasonably with global estimates of 600 million cases
each year [24].
Survey data in this study revealed that parents/
guardians and children often did not agree on the
number of pharyngitis episodes in the past year. More
than a quarter of parents or guardians (26%) did not
know or did not report how many pharyngitis epi-
sodes their child had experienced, and 14% of parents
or guardians reported a lower number of pharyngitis
episodes compared with their child. This finding has
possible implications for demand-side barriers to
proper treatment of GAS pharyngitis since school-
aged children would naturally depend on a caregiver
to help them seek medical attention for a sore throat.
Future work will aim to better understand factors that
underlie the discordance.
The number of sore throats was reported in this inves-
tigation to be approximately 50% higher in females com-
pared with males, a finding that was consistent in both
survey groups (students and parents or guardians). Fur-
thermore, two-thirds of the total number of students
treated for pharyngitis were girls. There have been anec-
dotal reports that GAS pharyngitis is more common in
females [27, 28], and several datasets demonstrate higher
rates of ARF or RHD in females compared with males
[8, 29–32]. It is not understood if this pattern is due
simply to sampling biases, differential access to health
services by women and girls [31], increased risk of ex-
posure to GAS (e.g., increased participation in childcare
activities), increased biological risk for acquisition of
GAS-related diseases, or other reasons [1]. The findings
of this study suggest the possibility that sore throat fre-
quency could be an influencing factor in the higher
prevalence of RHD in females, and underscore the im-
portance of educating girls and their families about
treatment of bacterial pharyngitis.
Table 5 Summary of key findings and implications for public awareness and education activities to reduce rheumatic heart disease
in Zambia
Findings Implications
Sore throat is perceived to be common in children and adolescents
in Zambia
Public awareness messaging does not need to establish that sore throat
is a problem locally; rather, the focus can be on validating public
perception and educating on best practices for clinical management
Parents/guardians and children have differing perceptions of the
frequency of sore throat in children in Zambia
Improved parent/guardian awareness may be needed to ensure vigilance
in surveillance for sore throat in children
Sore throat is reported more frequently in girls in Zambia compared
with boys
Investigators should explore potential cultural influences during
educational activities involving families and providers
Sore throat in children in Zambia is commonly not assessed by a
skilled practitioner, which risks sub-optimal treatment
Educating the public on need to seek skilled care for assessment of
pharyngitis is a main priority
Some children in Zambia have signs of potential bacterial
pharyngitis while attending school
There may be potential opportunity to improve capability at schools to
detect and manage sore throat
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Crucial to the prevention of RHD is appropriate diag-
nosis and treatment of bacterial pharyngitis with an anti-
biotic. It was an encouraging finding of this study that
families of students who sought treatment for pharyn-
gitis often did so at a site where skilled management of
sore throat could presumably take place—that is, at a
government clinic, private clinic, or hospital. Still, many
episodes of pharyngitis were reported to receive no
treatment or to have been treated at the student’s home.
In the local context, this generally meant non-
prescription treatment, such as gargling with salt water.
Less than one-third of students who had pharyngitis,
and half of students who had been treated for pharyn-
gitis, received an antibiotic. This rate of antibiotic use
may be appropriate overall given that GAS pharyngitis is
estimated to account for 20–30% of cases of sore throat
in children [22, 23, 33]. However, the degree to which
antibiotics are administered to those students most likely
to have GAS pharyngitis (compared with viral pharyn-
gitis) is unknown. In Zambia, resource limitations pre-
clude routine bacterial culture or antigen-based testing.
Additional operational research is therefore needed to
assess health workers’ ability to differentiate likely bac-
terial from viral pharyngitis using clinical criteria, as well
as to better understand their knowledge and skills in
treating suspected bacterial sore throat.
A limitation of this study was its reliance on reporting
by students and their caregivers (parents or guardians).
This investigation was designed to reveal current public
perceptions and practices related to sore throat and as
such did not incorporate methodologies for bacterial
surveillance investigation using cultures or rapid diag-
nostic tests. Therefore it was not possible to distinguish
between viral and bacterial etiologies of pharyngitis. An-
other limitation is that participants were asked to recall
clinical manifestations that occurred over the past year,
which could be challenging for some respondents, in-
cluding young children and caregivers that did not live
full-time with their children. This could have contrib-
uted to the discordance between the reports of students
and parents or guardians. Indeed, agreement in the
number of pharyngitis episodes reported by students
and parents/guardians was lower for children up to
12 years of age. While the study was not designed to
provide a precise measure of sore throat frequency, the
data gave some indication of the incidence of sore throat
in the population and more importantly describe public
perceptions that are essential to the design of public
health interventions [19]. Notably, the total prevalence
of sore throat at the time of screening was found to be
much higher than predicted based on the survey data
obtained. This could indicate that students were more
likely to report a minor sore throat (e.g., scratching
caused by dust) when asked at the time of screening,
and recalled more severe sore throat events when sur-
veyed about the previous year. Another possibility is that
students may have recalled minor sore throats from a
shorter time frame. In either case, survey data may have
underestimated the total burden of pharyngitis episodes,
and more closely reflected the incidence of clinically-
apparent pharyngitis. Another limitation is that the
population studied (students that attend school in
Zambia’s capital city) may not be representative of the
country as a whole; the incidence of GAS pharyngitis
may be higher in other parts of Zambia where access to
healthcare is poorer (e.g., rural areas and/or those with
relatively lower socioeconomic status). The implication
is that the frequency of GAS pharyngitis among school-
aged children in Zambia each year may be even greater
than the already large estimate presented here.
Conclusions
Pharyngitis is common among school-aged children and
adolescents in Zambia. Combining the results of this
study with bacteriologic data from other counties in
sub-Saharan Africa suggests that the attack-rate of GAS
pharyngitis is conservatively 0.08 per student-year, which
translates to more than 400,000 cases annually. Other
findings of this study are that parents or guardians ap-
pear to have variable knowledge about the frequency of
sore throat in their children and tend to report lower
frequencies, girls are reported to be affected by pharyn-
gitis more than boys, and management of pharyngitis
may be suboptimal for many children (both in terms of
percentage of families seeking medical care and type of
treatment administered). These results provide import-
ant insight into current perceptions and practices related
to sore throat in Zambia and will be used in the design
of public awareness activities aimed at reducing the risk
of RHD.
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